D E Bergsagel1. Show Affiliations » 1. University of Toronto, Ontario, Canada.
Abstract
Entities: Disease
Mesh: See more » Bone Marrow TransplantationChromosome AberrationsHumansInterferon Type I/therapeutic useLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy
Substances: See more » Interferon Type I
Year: 1990 PMID: 2312599 DOI: 10.1007/bf01612649
Source DB: PubMed Journal: J Cancer Res Clin Oncol ISSN: 0171-5216 Impact factor: 4.553